The gene-editing technique is effective for treating some illnesses but it's been too expensive to consider it for rare conditions. A new approach in the works could make it more widely available.
Dr. Jay Bhattacharya, a Stanford health researcher, is in line to lead the National Institutes of Health. Early in the pandemic he argued against lockdowns and focusing on people at highest risk.
If you've got a fever, cough, aches and pains, and you're wondering, "What virus got me this time?" Now you can find out, without taking a trip to the doctor.
If you've got a fever, cough, aches and pains, and you're wondering, "What virus got me this time?" Now you can find out, without taking a trip to the doctor.
The National Institutes of Health, the crown jewel of biomedical research in the U.S., could face big changes under the new Trump administration, some fueled by pandemic-era criticisms of the agency.
At a hospital in Kentucky, a man who had been declared dead after a drug overdose was moving and visibly crying as he was prepped for surgery to donate his vital organs. The surgery was stopped, and the man is alive three years later.
At a hospital in Kentucky, a man who had been declared dead after a drug overdose was moving and visibly crying as he was prepped for surgery to donate his vital organs. The surgery was stopped, and the man is alive three years later.
It’s been almost a year since the Food and Drug Administration approved the first genetic treatments for sickle cell disease. So far, only a few patients have received the long-awaited treatments.
The Food and Drug Administration is expected to give the green light to new COVID-19 vaccines this week to protect against recent variants of the coronavirus.
The nation — and Olympic athletes, like Noah Lyles — are in another summer surge of COVID infections. CDC officials say the virus has become endemic. That means it is here to stay in a predictable way.